Phoenix 8.0 provides scientists with more power, efficiency and transparency into PK/PD analysis and modeling for regulatory review
Including “non-ideal” components in the designs may be key to functional artificial proteins
Full ICH visible and UVA exposures are achievable in as little as 42 hours, less than half the time of many competing chambers
Scientists efficiently developed new and highly pure screw-shaped molecules for use in drug synthesis
New approach blocks key growth enzyme as well as the process that causes resistance to current treatments
Artemisinin-ALA co-treatment could kill cancer cells and suppress tumour growth with fewer side effects
Achievement using cryo-electron microscopy to aid gene research and drug development
Acquisition will expand BioIVT’s ADME-Toxicology product line
Researchers hope that by precisely modulating how our immune system responds to infection, they can develop new therapies that can be used to treat people with these serious diseases
Fluorescent kits designed for use with ScreenChip System for automatic screening and phenotyping
CURRENT ISSUE - March/2026
How Lab Leaders Can Prepare for Safety Crises That Don’t Follow the Script